admin

admin

Nicotine Addiction: Harm Reduction by E-cigarettes and Snus

Joel L. Nitzkin, MD, Public Health Physician, New Orleans, LA Email: jlnitzkin@gmail.com Follow Joel Q: Tobacco smoking remains the most preventable primary form of cancer causation in Americans. A recent Medscape column urged that harm reduction for confirmed nicotine addicts is the kindest and most effective strategy. How can products like “snus” be helpful? A: […]

Pharmacogenomics for Clinical Use of Cannabis

Saeed K. Alzghari, M.S., M.B.A. (HOM), Pharm.D., BCPS, Director of Clinical Pharmacy, Gulfstream Genomics, LLC., Dallas, TX; Email: salzghari@gulfdiagnostics.com Q: Proper use of Pharmacogenomics can inform better patient care in many potential ways. Pain relief by use of Cannabis instead of opioids shows substantial promise. How do you think pharmacogenomic study could guide intelligent clinical […]

Public Health Personalized Medicine

Gualberto Ruaño, MD, PhD, President, Genomas Inc.; Medical Director, Laboratory of Personalized Health; Hartford, CT; Email: g.ruano@genomas.net Q: Public participation by contributing specimens to assess personal genomic information is rapidly increasing. How might this expansion of testing become actually useful for the health of the public? A: The fields of public health and medicine share […]

Psychiatric Drug Use by Medical Students and Residents

Pamela Wible, MD, Founder of the Ideal Medical Care movement; Author of Physician Suicide Letters—Answered; Family medicine practitioner in Oregon; Follow Pamela Q: Medical students and residents are among the most important human resources in the United States. Yet we lose many during training due to suicide. Have you information you can share with our […]

The Worst Phony Cancer Cures

Stephen Barrett, MD, Retired Psychiatrist; Medical Editor for Quackwatch.org and 24 other consumer-protection Web sites; Publisher for Consumer Health Digest; Chapel Hill, NC; Email: sbinfo@quackwatch.org Q: Who tops your list as the most brazen promoters of phony cancer cures in the past 25 years? A: Three people come to mind: Gregory Caplinger, Hulda Clark, and […]

Nordic Country Tobacco Control

Astrid Nylenna, MD, Acting Head of Department, Department of Global Health, Norwegian Directorate of Health, Oslo, Norway; Email: Astrid.Nylenna@helsedir.no Follow Astrid Q: Norway has been very active in tobacco control and prevention with some success. To what do you attribute the success Norway has had and are there any lessons from other Scandinavian countries that […]

Surprise: Vitamin K2 and Cancer

Micki Jacobs, Independent Researcher, Dayton, OH; Email: mickijacobs@yahoo.com Q: You know a great deal about Vitamin K2 and its precursors in human health and disease. What is the best evidence of any value of Vitamin K2, Menadione, Menaquinone-4, and Menaquinone-7 in the prevention or treatment of any forms of cancer? A: Evidence and interest for […]

Precision Medicine in the Universal Healthcare System in the Netherlands

Jack A. Schalken, PhD, Professor of Experimental Urology, Radboud University Medical Center, Nijmegen, NL Email: Jack.Schalken@radboudumc.nl Q: Science is universal but the practice of medicine varies widely by geography, economics, and culture. The Netherlands is an advanced developed country with universal healthcare. How does your country approach the issue of precision or molecular oncology? A: […]

The Role of “Rapid Science” in Facilitating and Rewarding Collaboration in Biomedical Research

Sarah Greene, MS, Chief Executive Officer, Rapid Science, Brooklyn, NY; Email sg@rapidscience.org Follow SarahFollow Rapid Science Q: You are the leader of Rapid Science, an innovative initiative intended to speed up the process of research and validation of new information, and its use in practice, especially in Cancer. Can you explain this effort briefly for […]

Q&A: Air Traffic Control for Cancer

David K. Cundiff, MD, Retired internist and palliative care physician from LA County + USC Medical Center; Email: dkcundiff@whistleblowerdoctor.org Jeff Shrager, PhD, Director of Research, Cancer Commons; Adjunct Professor, Symbolic Systems Program, Stanford University; Email: jshrager@gmail.com Q: After May 17, 2017, you and Jeff Shrager engaged in a robust discussion about the place, if any, […]